SPLYZA and The University of Tokyo Hospital Begin Joint Research on AI-Powered Motion Analysis Technology

Key facts

  • SPLYZA and The University of Tokyo Hospital Begin Joint Research on AI-Powered Motion Analysis Technology
  • SPLYZA Inc. and The University of Tokyo Hospital have signed a joint research agreement to utilize SPLYZA's AI-powered markerless 3D motion analysis app, "SPLYZA Motion." The research aims to establish optimized multi-angle shooting protocols and improve measurement accuracy for patients with musculoskeletal diseases. This initiative seeks to overcome the limitations of traditional clinical evaluations by providing simple and highly accurate quantification of complex movements using AI technology.
  • Source: PR Times
  • Date: April 14, 2026

Direct answer

SPLYZA Inc. and The University of Tokyo Hospital have signed a joint research agreement to utilize SPLYZA's AI-powered markerless 3D motion analysis app, "SPLYZA Motion." The research aims to establish optimized multi-angle shooting protocols and improve measurement accuracy for patients with musculoskeletal diseases. This initiative seeks to overcome the limitations of traditional clinical evaluations by providing simple and highly accurate quantification of complex movements using AI technology.

Citation
SPLYZA and The University of Tokyo Hospital Begin Joint Research on AI-Powered Motion Analysis Technology (April 14, 2026), PR Times
Source
PR Times
Date
April 14, 2026
SPLYZA Inc. and The University of Tokyo Hospital have signed a joint research agreement to utilize SPLYZA's AI-powered markerless 3D motion analysis app, "SPLYZA Motion." The research aims to establish optimized multi-angle shooting protocols and improve measurement accuracy for patients with musculoskeletal diseases. This initiative seeks to overcome the limitations of traditional clinical evaluations by providing simple and highly accurate quantification of complex movements using AI technology.
researchNQ 68/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 14, 2026 at 20:00
  • 🔍 Collected: April 14, 2026 at 11:31
  • 🤖 AI Analyzed: April 16, 2026 at 19:18 (55h 46m after Collected)
SPLYZA Inc. (Headquarters: Hamamatsu City, Shizuoka Prefecture, Representative Director: Hiroyuki Doi, hereinafter "SPLYZA"), which supports "sports education and healthcare" through application development, and The University of Tokyo Hospital, Department of Orthopedic Surgery and Spine Surgery (Headquarters: Bunkyo-ku, Tokyo, Acting Hospital Director: Haruki Kume, hereinafter "The University of Tokyo Hospital"), signed a joint research agreement on March 17, 2026, regarding motion analysis technology utilizing "SPLYZA Motion," an AI-powered markerless 3D motion analysis app provided by SPLYZA.

【Research Background】
Currently, musculoskeletal diseases are cited as one of the primary causes of requiring long-term care in Japan. Among these, hip osteoarthritis significantly affects walking and standing movements, greatly reducing the quality of life (QOL). However, conventional clinical evaluations primarily rely on visual observation and photography from specific directions, making it difficult to easily and accurately quantify complex pelvic movements or left-right differences during walking.

This joint research aims to apply the AI analysis technology of "SPLYZA Motion," which prioritizes ease of use in clinical settings, to establish optimized multi-angle shooting protocols for patients with musculoskeletal diseases and improve measurement accuracy.

【About The University of Tokyo Hospital】
The University of Tokyo Hospital, originating from the Kanda Otamagaike Smallpox Vaccination Center established in 1858, is a hospital with over 160 years of history and tradition that has supported modern medical education in Japan. To fulfill its mission as a university hospital, it operates under the philosophy of "striving for the development of clinical medicine and the training of medical professionals, and providing optimal medical care to individual patients," engaging in clinical practice, research, and education.

【What is SPLYZA Motion?】
https://motion.products.splyza.com/
An AI-powered markerless 3D motion analysis app. The service was launched in 2022, and as of April 2026, it has been introduced in over 200 facilities, including educational institutions and medical facilities.

【About SPLYZA Inc.】
https://www.splyza.com/
Company Name: SPLYZA Inc.
Location: 16-13 Aioicho, Chuo-ku, Hamamatsu City, Shizuoka Prefecture
Representative: Hiroyuki Doi, Representative Director
Factbook: https://www.splyza.com/company/factbook.html

FAQ

What is SPLYZA Motion?

SPLYZA Motion is an AI-powered markerless 3D motion analysis application. It was launched in 2022 and is currently used in over 200 facilities, including educational and medical institutions.

What is the purpose of this joint research?

The purpose is to establish optimized multi-angle shooting protocols for patients with musculoskeletal diseases and improve measurement accuracy using AI analysis technology.

What are the key facts in this article?

SPLYZA Inc. and The University of Tokyo Hospital have signed a joint research agreement to utilize SPLYZA's AI-powered markerless 3D motion analysis app, "SPLYZA Motion." The research aims to establish optimized multi-angle shooting protocols and improve measurement accuracy for patients with musculoskeletal diseases. This initiative seeks to overcome the limitations of traditional clinical evaluations by providing simple and highly accurate quantification of complex movements using AI technology.